Inflammatory Cytokine Inhibition with Combination Daclizumab and Infliximab for Steroid Refractory Acute Graft-Versus-Host Disease

Treatment options for steroid-refractory GVHD (SR-GVHD) are unsatisfactory and prognosis is poor. Inflammatory cytokines IL-2 and TNF-α are important mediators of GVHD, and may be critical targets for therapy. We retrospectively reviewed our experience using combination anti-cytokine therapy of dacl...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Rager, Alison, Frey, Noelle, Goldstein, Steven C, Reshef, Ran, Hexner, Elizabeth O, Loren, Alison, Luger, Selina M, Perl, Alexander, Tsai, Donald, Davis, Jennifer, Vozniak, Michael, Smith, Jacqueline, Stadtmauer, Edward A, Porter, David L
Formato: Artigo
Lenguaje:Inglês
Publicado: 2010
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3010487/
https://ncbi.nlm.nih.gov/pubmed/20498647
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bmt.2010.117
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares